Herceptin | search
Click here to view Herceptin news from 60+ newspapers.
Bookmark or Share- Herceptin (Trastuzumab): Side Effects, How it Works, and MoreHerceptin (chemical name: trastuzumab) can be used to treat HER2-positive breast cancer that is either early-stage or advanced-stage/metastatic. Herceptin is currently approved by the U.S. Food and Drug Administration: to treat metastatic HER2-positive breast cancer to stop the cancer from growing.
- Trastuzumab - WikipediaTrastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication.
- Trastuzumab - NCI - National Cancer InstituteHerceptin. Herzuma. Kanjinti. Ogivri. Ontruzant. Trazimera. FDA Approved. Yes. FDA label information for this drug is available at DailyMed. Use in Cancer. Trastuzumab is approved to be used alone or with other drugs to treat: Breast cancer that is HER2 positive (HER2+). It is used in patients with: Hormone receptor-negative or high-risk cancer.
- What to Know About Herceptin for HER2 - WebMDFind out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.
- Herceptin: Uses, Dosage & Side Effects - Drugs.comWhat is Herceptin? Herceptin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Herceptin is used to treat certain types of breast cancer or stomach cancer. Other cancer medicines are sometimes used in combination with Herceptin.
More
